BMX-001 clinical trials
Also written BMX-001.
How each study uses BMX-001 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the BMX-001 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 3
BioMimetix JV, LLC (5) · University of Nebraska (2) · NRG Oncology (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test BMX-001.
- Jan 2027Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerPhase 2 · NRG Oncology
- Mar 2027BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial CancerPhase 1/2 · BioMimetix JV, LLC
Studies
Open first, then newest update. How each study uses BMX-001 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001RecruitingPhase 2University of NebraskaNCT05254327Written as BMX-001
- Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerRecruitingPhase 2NRG OncologyNCT06532279Written as MnSOD Mimetic BMX-001
- BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial CancerNot yet recruitingPhase 1/2BioMimetix JV, LLCNCT06620029Written as BMX-001
- Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal CancerActive, not recruitingPhase 1/2University of NebraskaNCT03386500Written as BMX-001
- Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001CompletedPhase 1/2BioMimetix JV, LLCNCT02655601Written as BMX-001
- A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain RadiotherapyTerminatedPhase 1/2BioMimetix JV, LLCNCT03608020Written as BMX-001
- A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck CancerCompletedPhase 1/2BioMimetix JV, LLCNCT02990468Written as BMX-001
- Trial of BMX-001 or Placebo in Head and Neck Cancer PatientsWithdrawnPhase 2BioMimetix JV, LLCNCT04607642Written as BMX-001
Codes
What other systems call BMX-001 · ClinicalTrials.gg INT017302
- UNII (FDA) MIJ02RO47FBMX-001Confirmed FDA, Wikidata
- Wikidata Q27284052bmx-001Confirmed FDA, Wikidata
- NCI Thesaurus C125666MnSOD Mimetic BMX-001One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | MIJ02RO47F | BMX-001 | Confirmed FDA, Wikidata |
| Wikidata | Q27284052 | bmx-001 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C125666 | MnSOD Mimetic BMX-001 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.